DePuy resolves two part hip cup licence dispute:
This article was originally published in Clinica
DePuy and Joint Medical Products, both Johnson & Johnson companies, have settled a patent suit brought by BTG, a UK intellectual property commercialising company and licensor of two part hip cups to a number of orthopaedic companies. BTG brought the action in October 1999 regarding a dispute under a pre-existing agreement. The mediated settlement came about because of the "close working relationship" between the companies. BTG claims that 70% of the two part hip products sold in the US are licensed from BTG.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.